Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Erdosteine is a potent mucoregulatory agent widely utilized in the management of chronic obstructive pulmonary disease (COPD) and other respiratory conditions characterized by excessive or viscous mucus production. Chemically known as 2-ethyl-3,5-dimethyl-4-morpholinylthio-1,4-dihydro-2H-thiopyran-6-one, its molecular formula is C13H19NO3S2. The compound is uniquely identified by the CAS number 78903-35-2. Structurally, Erdosteine features a thiol group that plays a critical role in its pharmacological mechanism of action. Unlike traditional expectorants that primarily act to increase fluid secretion, Erdosteine functions as a direct mucolytic and antioxidant agent. It works by breaking down disulfide bonds within the mucus glycoproteins, thereby reducing viscosity and elasticity, which facilitates easier clearance from the airways through coughing.
Beyond its primary mucolytic effects, Erdosteine exhibits significant antioxidant properties. It effectively scavenges free radicals generated during inflammatory processes in the lungs, protecting lung tissue from oxidative stress-induced damage. This dual action makes it particularly beneficial for patients with chronic bronchitis and COPD, where inflammation and mucus hypersecretion are key pathological features. Clinical studies have demonstrated that Erdosteine improves sputum clearance rates, reduces the frequency of exacerbations, and enhances overall quality of life for affected individuals. Its favorable safety profile allows for long-term use with minimal side effects, typically limited to mild gastrointestinal disturbances. Available in various formulations including capsules, granules, and tablets, Erdosteine is prescribed globally as a first-line therapy for managing chronic respiratory disorders. By targeting both the physical consistency of mucus and the underlying oxidative stress, this drug offers a comprehensive therapeutic approach to restoring normal respiratory function and preventing disease progression in patients suffering from chronic airway obstructions.